You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

CLINICAL TRIALS PROFILE FOR SODIUM MONOFLUOROPHOSPHATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Sodium Monofluorophosphate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00708097 ↗ In Situ Caries Efficacy of Fluoride Toothpastes Completed GlaxoSmithKline Phase 3 2008-04-01 This study is to evaluate the effect of fluoride dentifrices on enamel with artificial caries lesions in an in situ model
NCT00708123 ↗ In Situ Caries of Fluoride Toothpastes Completed GlaxoSmithKline Phase 3 2007-11-01 This study is to evaluate the effect of fluoride dentifrices on enamel with artificial caries lesions in an in situ model.
NCT00759031 ↗ Investigation of Dental Plaque and Gingival Index Completed Colgate Palmolive Phase 3 2008-02-01 Investigation of inhibitory effect of prototype toothpaste on dental plaque formation via modified gingival margin plaque index method.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Monofluorophosphate

Condition Name

Condition Name for Sodium Monofluorophosphate
Intervention Trials
Dentine Hypersensitivity 5
Caries 4
Dentin Sensitivity 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Monofluorophosphate
Intervention Trials
Hypersensitivity 9
Dentin Sensitivity 8
Gingivitis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Monofluorophosphate

Trials by Country

Trials by Country for Sodium Monofluorophosphate
Location Trials
United States 11
Ireland 2
Chile 1
Brazil 1
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Monofluorophosphate
Location Trials
Indiana 5
Nevada 4
New York 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Monofluorophosphate

Clinical Trial Phase

Clinical Trial Phase for Sodium Monofluorophosphate
Clinical Trial Phase Trials
Phase 4 2
Phase 3 11
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Monofluorophosphate
Clinical Trial Phase Trials
Completed 17
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Monofluorophosphate

Sponsor Name

Sponsor Name for Sodium Monofluorophosphate
Sponsor Trials
GlaxoSmithKline 11
University of Campinas, Brazil 2
Colgate Palmolive 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Monofluorophosphate
Sponsor Trials
Industry 14
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.